• Refine Query
  • Source
  • Publication year
  • to
  • Language
  • 274
  • 183
  • 47
  • 31
  • 28
  • 16
  • 15
  • 9
  • 8
  • 7
  • 7
  • 7
  • 7
  • 7
  • 7
  • Tagged with
  • 797
  • 797
  • 185
  • 118
  • 96
  • 81
  • 73
  • 72
  • 68
  • 63
  • 62
  • 61
  • 54
  • 51
  • 45
  • About
  • The Global ETD Search service is a free service for researchers to find electronic theses and dissertations. This service is provided by the Networked Digital Library of Theses and Dissertations.
    Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.
21

Serum concentration levels of 25(OH)D and injury reports in NCAA Division I football players

McGill, Lauren Elyse 07 October 2014 (has links)
Vitamin D deficiency has been linked with many health problems. Early research demonstrated the importance of vitamin D for bone health, but it may also play a larger role than first reported in muscle health and function. Specifically, low vitamin D may hinder athletic performance, as such evaluation of serum vitamin D levels in high volume training athletes has merit. The purpose of this study was to evaluate serum levels of 25(OH)D in college athletes to determine how many had levels below the recommended values. Data from student-athletes who were attending a large university in the south included: serum vitamin D levels, demographics information, and injury reports. Mean serum vitamin D level for the group was 34.17 ng/mL ± 0.88. Average injury for the group was 1.3± 0.14. The mean value of serum vitamin D for Caucasian players was 38.3 ng/mL ± 1.33 with a range of 23-59 ng/mL. The mean value of serum vitamin D for African American players was 31.16 ng/mL ± 1.08 with a range of 16-52 ng/mL. African American players had significantly lower serum vitamin D levels (p<0.01) than Caucasian players. Players with one or more injury had significantly lower serum vitamin D values (p<0.05) than players who had zero injuries. Forty-eight players (44.4%) had insufficient levels of vitamin D (20-31.9ng/ml). 60 players (55.6%) had values within normal limits (>32 ng/ml). Players with one or more musculoskeletal injury or fracture had significantly lower serum vitamin D levels (p<0.05) compared to players that had zero injuries. African American players had significantly lower serum vitamin D levels (p<0.01) compared to Caucasian players. It is important for athletes to monitor serum vitamin D levels and adhere to a supplementation protocol when levels are insufficient. / text
22

Clinical and experimental studies on vitamin D and PTH metabolism

Osman, O. M. January 1988 (has links)
No description available.
23

Development and application of the one-pot Julia olefination

Blakemore, Paul Richard January 1999 (has links)
No description available.
24

Immunomodulatory actions of vitamin D in the protection against acute respiratory infections

Greiller, Claire Louise January 2014 (has links)
Introduction: Vitamin D is a micronutrient that possesses immunomodulatory actions. Higher vitamin D status has been associated with decreased incidence of acute respiratory infections (ARI) in a number of observational studies. However, mechanistic in vitro work investigating effects of vitamin D on the immune response to ARIs is lacking, especially for rhinovirus, which is the most common respiratory pathogen. Results of clinical trials of vitamin D supplementation in the prevention of ARIs have also been conflicting, in that some demonstrate a protective effect of this intervention against ARI, while others do not. Methods: An immunological assay of ex vivo stimulation with TLR ligands and pathogens in blood samples from participants with asthma, COPD or neither condition in three randomised controlled trials of vitamin D supplementation for the prevention of ARI and exacerbations was developed. This assay was used in conjunction with cellular profiling of clinical trial blood and sputum samples, and a rhinovirus-infected human alveolar cell line (A549 cells) to determine the effects of vitamin D in the protection against acute respiratory infections. Results: The main finding of cell culture experiments was that A549 cells pre-treated with physiological concentrations of 25-hydroxyvitamin D (25[OH]D, the major circulating vitamin D metabolite) had increased resistance to rhinovirus infection, which was associated with attenuation of rhinovirus-induced intercellular adhesion molecule-1 (ICAM-1) and platelet-activating factor receptor (PafR) expression. Immunological analysis of clinical trial samples did not demonstrate any consistent effect of bolus-dose vitamin D supplementation on circulating or pathogen-stimulated inflammatory profiles, or on inflammatory indices in induced sputum. Conclusions: Co-incubation with 25(OH)D was associated with transient protection against rhinovirus infection in a respiratory epithelial cell line in vitro, but these findings did not translate to any changes in cellular profile or inflammatory mediator release in clinical trials samples following in vivo vitamin D supplementation.
25

Vitamin D status and cardiometabolic risk factors in black African and Indian populations of South Africa

George, Jaya Anna 09 September 2014 (has links)
Background: South Africa is in the midst of a health transition that is characterized by a high burden of both infectious diseases and non-communicable diseases. One of the drivers of non-communicable diseases in South Africa is the current epidemic of obesity. Vitamin D deficiency, which is defined by 25(OH)D levels in blood, has been reported to be a risk factor for cardiovascular disease and shares a number of risk factors with those traditionally linked to non-communicable diseases. Osteoporosis is another non-communicable disease that is reportedly increasing in prevalence worldwide and may be linked to vitamin D levels and to body fat. There is limited data on 25(OH)D levels in South Africa and its association with cardiovascular risk factors. There is also limited data on body composition including bone mineral density. Aims: The aims of this thesis were to describe 25(OH)D levels in healthy Black African and Indian subjects recruited from the greater Johannesburg metropolis and to determine if differences in 25(OH)D levels contributed to differences in cardiovascular risk. A further aim was to describe body composition in both ethnic groups and to see if differences in body composition contribute to differences in 25(OH)D levels or to differences in bone mineral density and to determine if differences in bone mineral density are mediated by differences in 25(OH)D. Methods: This was a cross sectional study carried out from July 2011 to March 2012 on 714 male and female subjects (male: female=340:374) of whom 371 were Black African and 343 were Indian. Subjects were recruited via the caregivers of the Birth to Twenty cohort. The first step was a descriptive analysis of 25(OH)D as well as its predictors including whole body fat, visceral and subcutaneous adiposity. This was followed by examining the associations of 25(OH)D and parathyroid hormone with cardiovascular risk factors that comprise the metabolic syndrome. Final analysis was description of bone mineral density according to ethnicity and gender and the contribution of lean mass, sub-total fat mass, visceral and subcutaneous adiposity to bone mineral density in each ethnic group. Results: Vitamin D deficiency was very prevalent in Indians, 28.6% in comparison to 5.1% in the Black African group (p<0.0001). In both groups season of collection was a positive predictor and PTH was negatively associated with 25(OH)D. Neither whole body fat nor visceral or subcutaneous adiposity was predictive of 25(OH)D in either group. Using the harmonized definition of the metabolic syndrome (Met S), was diagnosed in 29% of the Black African and 46% of the Indian subjects (p<0.0001). Subjects with Met S had higher PTH than those without (p<0.0001), whilst 25(OH)D levels were not significantly different (p=0.50). Logistic regression analysis showed that Indian ethnicity (OR 2.24; 95% CIs 1.57, 3.18; p<0.0001) and raised PTH (OR 2.48; 95% CIs 1.01, 6.08; p=0.04) adjusted for 25(OH)D) produced an increased risk of Met S but 25(OH)D did not (OR 1.25; 95% CIs 0.67, 2.24; p=0.48). Whole body, hip, femoral neck and lumbar spine bone mineral density were significantly higher in Black African than Indian subjects (p<0.001 for all). Whole body lean mass positively associated with bone mineral density at all sites in both ethnic groups (p<0.001 for all), and partially explained the higher bone mineral density in Black African females compared to Indian females. Whole body fat mass correlated positively with lumbar bone mineral density in Black African (p=0.001) and inversely with sub-total bone mineral density in Indian subjects (p<0.0001). Visceral adiposity correlated inversely with sub-total bone mineral density in the Black African subjects (p=0.037) and with lumbar bone mineral density in the Indian group (p=0.005). No association was found between serum 25(OH)D and bone mineral density. PTH was inversely associated with hip bone mineral density in the Black African group (p=0.01) and with sub-total (p=0.002), hip (p=0.001) and femoral bone mineral density (p<0.0001) in the Indian group. Conclusions: This study highlighted the high prevalence of vitamin D deficiency in the Indian population and the fact that local conditions such as sunshine exposure and season of collection of blood are important determinants of 25(OH)D levels. It also showed that Indian ethnicity and PTH are risk factors for the Met S, but differences in risk between both ethnic groups are not due to differences in 25(OH)D levels. The thesis also showed that there are significant differences in bone mineral density across ethnicity, with lean mass an important contributor to bone mineral density across race and gender.
26

Prostaglandin and Vitamin D - some model studies.

Wong, Henry She Lai. January 1970 (has links)
No description available.
27

Nuclear mechanism of action of 1α, 25-dihydroxyvitamin D₃

Zerwekh, Joseph Edward, 1948- January 1976 (has links)
No description available.
28

Determination of 1 ,25-dihydroxy calciferol

Abellana, Jocelyn A. January 1984 (has links)
published_or_final_version / Medical Sciences / Master / Master of Medical Sciences
29

1α,25-DIHYDROXYVITAMIN D₃ RECEPTORS IN INTESTINE: PROPERTIES AND UTILIZATION IN AN ASSAY FOR THIS STEROL HORMONE

Brumbaugh, Peter Flory, 1949- January 1975 (has links)
No description available.
30

The homeostatic control of the kidney 25-hydroxyvitamin D₃1α-hydroxylase

Cork, Douglas James, 1950- January 1974 (has links)
No description available.

Page generated in 0.0674 seconds